Oguzhan Alagoz - Publications

Affiliations: 
Industrial Engineering University of Wisconsin, Madison, Madison, WI 
Area:
Operations Research, Industrial Engineering, Radiology, Health Care Management
Website:
https://directory.engr.wisc.edu/ie/faculty/alagoz_oguzhan

70 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2025 Alagoz O, Caswell-Jin JL, de Koning HJ, Huang H, Huang X, Lee SJ, Li Y, Plevritis SK, Sarkar S, Schechter CB, Stout NK, Trentham-Dietz A, van Ravesteyn N, Lowry KP. Mathematical Modeling to Address Questions in Breast Cancer Screening: An Overview of the Breast Cancer Models of the Cancer Intervention and Surveillance Modeling Network. Journal of Breast Imaging. PMID 40036318 DOI: 10.1093/jbi/wbaf003  0.463
2024 Stout NK, Miglioretti DL, Su YR, Lee CI, Abraham L, Alagoz O, de Koning HJ, Hampton JM, Henderson L, Lowry KP, Mandelblatt JS, Onega T, Schechter CB, Sprague BL, Stein S, et al. Breast Cancer Screening Using Mammography, Digital Breast Tomosynthesis, and Magnetic Resonance Imaging by Breast Density. Jama Internal Medicine. PMID 39186304 DOI: 10.1001/jamainternmed.2024.4224  0.372
2024 Basmadjian RB, Ruan Y, Hutchinson JM, Warkentin MT, Alagoz O, Coldman A, Brenner DR. Examining breast cancer screening recommendations in Canada: The projected resource impact of screening among women aged 40-49. Journal of Medical Screening. 9691413241267845. PMID 39106352 DOI: 10.1177/09691413241267845  0.368
2024 Trentham-Dietz A, Chapman CH, Jayasekera J, Lowry KP, Heckman-Stoddard BM, Hampton JM, Caswell-Jin JL, Gangnon RE, Lu Y, Huang H, Stein S, Sun L, Gil Quessep EJ, Yang Y, Lu Y, ... ... Alagoz O, et al. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force. Jama. PMID 38687505 DOI: 10.1001/jama.2023.24766  0.387
2024 Caswell-Jin JL, Sun LP, Munoz D, Lu Y, Li Y, Huang H, Hampton JM, Song J, Jayasekera J, Schechter C, Alagoz O, Stout NK, Trentham-Dietz A, Lee SJ, Huang X, et al. Analysis of Breast Cancer Mortality in the US-1975 to 2019. Jama. 331: 233-241. PMID 38227031 DOI: 10.1001/jama.2023.25881  0.388
2022 Burnside ES, Schrager S, DuBenske L, Keevil J, Little T, Trentham-Dietz A, Rolland B, Shah D, Alagoz O. Team Science Principles Enhance Cancer Care Delivery Quality Improvement: Interdisciplinary Implementation of Breast Cancer Screening Shared Decision Making. Jco Oncology Practice. OP2200355. PMID 36126243 DOI: 10.1200/OP.22.00355  0.368
2022 Tunç S, Alagoz O, Burnside ES. A new perspective on breast cancer diagnostic guidelines to reduce overdiagnosis. Production and Operations Management. 31: 2361-2378. PMID 35915601 DOI: 10.1111/poms.13691  0.464
2022 Ergun MA, Hajjar A, Alagoz O, Rampurwala M. Optimal breast cancer risk reduction policies tailored to personal risk level. Health Care Management Science. PMID 35687269 DOI: 10.1007/s10729-022-09596-2  0.352
2021 Yeh JM, Lowry KP, Schechter CB, Diller LR, O'Brien G, Alagoz O, Armstrong GT, Hampton JM, Hudson MM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Nathan PC, et al. Breast Cancer Screening Among Childhood Cancer Survivors Treated Without Chest Radiation: Clinical Benefits and Cost-Effectiveness. Journal of the National Cancer Institute. PMID 34324686 DOI: 10.1093/jnci/djab149  0.416
2021 Alagoz O, Lowry KP, Kurian AW, Mandelblatt JS, Ergun MA, Huang H, Lee SJ, Schechter CB, Tosteson ANA, Miglioretti DL, Trentham-Dietz A, Nyante SJ, Kerlikowske K, Sprague BL, Stout NK. Impact of the COVID-19 Pandemic on Breast Cancer Mortality in the US: Estimates From Collaborative Simulation Modeling. Journal of the National Cancer Institute. PMID 34258611 DOI: 10.1093/jnci/djab097  0.408
2021 Trentham-Dietz A, Alagoz O, Chapman C, Huang X, Jayasekera J, van Ravesteyn NT, Lee SJ, Schechter CB, Yeh JM, Plevritis SK, Mandelblatt JS. Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts. Plos Computational Biology. 17: e1009020. PMID 34138842 DOI: 10.1371/journal.pcbi.1009020  0.461
2021 van Ravesteyn NT, Schechter CB, Hampton JM, Alagoz O, van den Broek JJ, Kerlikowske K, Mandelblatt JS, Miglioretti DL, Sprague BL, Stout NK, de Koning HJ, Trentham-Dietz A, Tosteson ANA. Trade-Offs Between Harms and Benefits of Different Breast Cancer Screening Intervals Among Low-Risk Women. Journal of the National Cancer Institute. PMID 33515225 DOI: 10.1093/jnci/djaa218  0.411
2020 Yeh JM, Lowry KP, Schechter CB, Diller LR, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK. Clinical Benefits, Harms, and Cost-Effectiveness of Breast Cancer Screening for Survivors of Childhood Cancer Treated With Chest Radiation: A Comparative Modeling Study. Annals of Internal Medicine. PMID 32628531 DOI: 10.7326/M19-3481  0.489
2019 Lowry KP, Trentham-Dietz A, Schechter CB, Alagoz O, Barlow WE, Burnside ES, Conant EF, Hampton JM, Huang H, Kerlikowske K, Lee SJ, Miglioretti DL, Sprague BL, Tosteson ANA, Yaffe M, et al. Long-term Outcomes and Cost-effectiveness of Breast Cancer Screening with Digital Breast Tomosynthesis in the United States. Journal of the National Cancer Institute. PMID 31503283 DOI: 10.1093/Jnci/Djz184  0.489
2019 Hajjar A, Ergun MA, Alagoz O, Rampurwala M. Cost-effectiveness of adjuvant paclitaxel and trastuzumab for early-stage node-negative, HER2-positive breast cancer. Plos One. 14: e0217778. PMID 31166995 DOI: 10.1371/journal.pone.0217778  0.36
2019 Yeh J, Lowry KP, Schechter CB, Diller L, Alagoz O, Armstrong GT, Hampton JM, Leisenring W, Liu Q, Mandelblatt JS, Miglioretti DL, Moskowitz CS, Oeffinger KC, Trentham-Dietz A, Stout NK. Clinical outcomes and cost-effectiveness of breast cancer screening for childhood cancer survivors treated with chest radiation: A comparative modeling study. Journal of Clinical Oncology. 37: 6525-6525. DOI: 10.1200/Jco.2019.37.15_Suppl.6525  0.529
2018 Ayvaci MUS, Alagoz O, Ahsen ME, Burnside ES. Preference-Sensitive Management of Post-Mammography Decisions in Breast Cancer Diagnosis. Production and Operations Management. 27: 2313-2338. PMID 31031555 DOI: 10.1111/Poms.12897  0.438
2018 Yaffe MJ, Mittmann N, Alagoz O, Trentham-Dietz A, Tosteson AN, Stout NK. The effect of mammography screening regimen on incidence-based breast cancer mortality. Journal of Medical Screening. 969141318780152. PMID 30049249 DOI: 10.1177/0969141318780152  0.489
2018 Alagoz O, Berry DA, de Koning HJ, Feuer EJ, Lee SJ, Plevritis SK, Schechter CB, Stout NK, Trentham-Dietz A, Mandelblatt JS. Introduction to the Cancer Intervention and Surveillance Modeling Network (CISNET) Breast Cancer Models. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 3S-8S. PMID 29554472 DOI: 10.1177/0272989X17737507  0.526
2018 Alagoz O, Ergun MA, Cevik M, Sprague BL, Fryback DG, Gangnon RE, Hampton JM, Stout NK, Trentham-Dietz A. The University of Wisconsin Breast Cancer Epidemiology Simulation Model: An Update. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 99S-111S. PMID 29554470 DOI: 10.1177/0272989X17711927  0.46
2018 van den Broek JJ, van Ravesteyn NT, Mandelblatt JS, Huang H, Ergun MA, Burnside ES, Xu C, Li Y, Alagoz O, Lee SJ, Stout NK, Song J, Trentham-Dietz A, Plevritis SK, Moss SM, et al. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 140S-150S. PMID 29554468 DOI: 10.1177/0272989X17718168  0.385
2018 Gangnon RE, Stout NK, Alagoz O, Hampton JM, Sprague BL, Trentham-Dietz A. Contribution of Breast Cancer to Overall Mortality for US Women. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 24S-31S. PMID 29554467 DOI: 10.1177/0272989X17717981  0.466
2018 van Ravesteyn NT, van den Broek JJ, Li X, Weedon-Fekjær H, Schechter CB, Alagoz O, Huang X, Weaver DL, Burnside ES, Punglia RS, de Koning HJ, Lee SJ. Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 38: 126S-139S. PMID 29554463 DOI: 10.1177/0272989X17729358  0.479
2018 Mittmann N, Stout NK, Tosteson ANA, Trentham-Dietz A, Alagoz O, Yaffe MJ. Cost-effectiveness of mammography from a publicly funded health care system perspective. Cmaj Open. 6: E77-E86. PMID 29440151 DOI: 10.9778/cmajo.20170106  0.401
2018 Plevritis SK, Munoz D, Kurian AW, Stout NK, Alagoz O, Near AM, Lee SJ, van den Broek JJ, Huang X, Schechter CB, Sprague BL, Song J, de Koning HJ, Trentham-Dietz A, van Ravesteyn NT, et al. Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012. Jama. 319: 154-164. PMID 29318276 DOI: 10.1001/Jama.2017.19130  0.378
2018 Cevik M, Ayer T, Alagoz O, Sprague BL. Analysis of Mammography Screening Policies under Resource Constraints Production and Operations Management. 27: 949-972. DOI: 10.1111/Poms.12842  0.484
2017 Burnside ES, Lee SJ, Bennette C, Near AM, Alagoz O, Huang H, van den Broek JJ, Kim JY, Ergun MA, van Ravesteyn NT, Stout NK, de Koning HJ, Mandelblatt JS. Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age. Mdm Policy & Practice. 2. PMID 29376135  0.409
2017 Trentham-Dietz A, Ergun MA, Alagoz O, Stout NK, Gangnon RE, Hampton JM, Dittus K, James TA, Vacek PM, Herschorn SD, Burnside ES, Tosteson ANA, Weaver DL, Sprague BL. Comparative effectiveness of incorporating a hypothetical DCIS prognostic marker into breast cancer screening. Breast Cancer Research and Treatment. PMID 29185118 DOI: 10.1007/S10549-017-4582-0  0.392
2017 Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, et al. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29150480 DOI: 10.1158/1055-9965.Epi-17-0378  0.319
2016 Trentham-Dietz A, Kerlikowske K, Stout NK, Miglioretti DL, Schechter CB, Ergun MA, van den Broek JJ, Alagoz O, Sprague BL, van Ravesteyn NT, Near AM, Gangnon RE, Hampton JM, Chandler Y, de Koning HJ, et al. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes. Annals of Internal Medicine. PMID 27548583 DOI: 10.7326/M16-0476  0.319
2016 Erenay FS, Alagoz O, Banerjee R, Said A, Cima RR. Cost-effectiveness of alternative colonoscopy surveillance strategies to mitigate metachronous colorectal cancer incidence. Cancer. PMID 27248907 DOI: 10.1002/Cncr.30091  0.361
2016 Mandelblatt JS, Stout NK, Schechter CB, van den Broek JJ, Miglioretti DL, Krapcho M, Trentham-Dietz A, Munoz D, Lee SJ, Berry DA, van Ravesteyn NT, Alagoz O, Kerlikowske K, Tosteson AN, Near AM, et al. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies. Annals of Internal Medicine. PMID 26756606 DOI: 10.7326/M15-1536  0.459
2016 Kim JJ, Tosteson AN, Zauber AG, Sprague BL, Stout NK, Alagoz O, Trentham-Dietz A, Armstrong K, Pruitt SL, Rutter CM. Cancer Models and Real-world Data: Better Together. Journal of the National Cancer Institute. 108. PMID 26538628 DOI: 10.1093/Jnci/Djv316  0.436
2016 Ayer T, Alagoz O, Stout NK, Burnside ES. Heterogeneity in women's adherence and its role in optimal breast cancer screening policies Management Science. 62: 1339-1362. DOI: 10.1287/Mnsc.2015.2180  0.406
2015 Wu Y, Liu J, Del Rio AM, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a clinical utility framework to evaluate prediction models in radiogenomics. Proceedings of Spie--the International Society For Optical Engineering. 9416. PMID 27095854 DOI: 10.1117/12.2081954  0.482
2015 Wu Y, Abbey CK, Chen X, Liu J, Page DC, Alagoz O, Peissig P, Onitilo AA, Burnside ES. Developing a utility decision framework to evaluate predictive models in breast cancer risk estimation. Journal of Medical Imaging (Bellingham, Wash.). 2: 041005. PMID 26835489 DOI: 10.1117/1.Jmi.2.4.041005  0.527
2015 Mittmann NM, Stout NK, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Yaffe MJ. Total cost-effectiveness of mammography screening strategies. Health Reports. 26: 16-25. PMID 26676235  0.376
2015 Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK. Clinical outcomes of modelling mammography screening strategies. Health Reports. 26: 9-15. PMID 26676234  0.32
2015 Yaffe MJ, Mittmann N, Lee P, Tosteson AN, Trentham-Dietz A, Alagoz O, Stout NK. Modelling mammography screening for breast cancer in the Canadian context: Modification and testing of a microsimulation model. Health Reports. 26: 3-8. PMID 26676233  0.391
2015 van Ravesteyn NT, Stout NK, Schechter CB, Heijnsdijk EA, Alagoz O, Trentham-Dietz A, Mandelblatt JS, de Koning HJ. Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis. Journal of the National Cancer Institute. 107. PMID 25948872 DOI: 10.1093/Jnci/Djv103  0.445
2015 Gangnon RE, Sprague BL, Stout NK, Alagoz O, Weedon-Fekjær H, Holford TR, Trentham-Dietz A. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 905-12. PMID 25787716 DOI: 10.1158/1055-9965.Epi-14-1286  0.399
2015 Sprague BL, Stout NK, Schechter C, van Ravesteyn NT, Cevik M, Alagoz O, Lee CI, van den Broek JJ, Miglioretti DL, Mandelblatt JS, de Koning HJ, Kerlikowske K, Lehman CD, Tosteson AN. Benefits, harms, and cost-effectiveness of supplemental ultrasonography screening for women with dense breasts. Annals of Internal Medicine. 162: 157-66. PMID 25486550 DOI: 10.7326/M14-0692  0.398
2014 Munoz D, Near AM, van Ravesteyn NT, Lee SJ, Schechter CB, Alagoz O, Berry DA, Burnside ES, Chang Y, Chisholm G, de Koning HJ, Ali Ergun M, Heijnsdijk EA, Huang H, Stout NK, et al. Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality. Journal of the National Cancer Institute. 106. PMID 25255803 DOI: 10.1093/Jnci/Dju289  0.347
2014 Ayvaci MU, Alagoz O, Chhatwal J, Munoz del Rio A, Sickles EA, Nassif H, Kerlikowske K, Burnside ES. Predicting invasive breast cancer versus DCIS in different age groups. Bmc Cancer. 14: 584. PMID 25112586 DOI: 10.1186/1471-2407-14-584  0.753
2014 Wu Y, Alagoz O, Vanness DJ, Trentham-Dietz A, Burnside ES. Pursuing optimal thresholds to recommend breast biopsy by quantifying the value of tomosynthesis. Proceedings of Spie--the International Society For Optical Engineering. 9037: 90370U. PMID 25076829 DOI: 10.1117/12.2042905  0.527
2014 Stout NK, Lee SJ, Schechter CB, Kerlikowske K, Alagoz O, Berry D, Buist DS, Cevik M, Chisholm G, de Koning HJ, Huang H, Hubbard RA, Miglioretti DL, Munsell MF, Trentham-Dietz A, et al. Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography. Journal of the National Cancer Institute. 106: dju092. PMID 24872543 DOI: 10.1093/Jnci/Dju092  0.305
2014 Erenay FS, Alagoz O, Said A. Optimizing colonoscopy screening for colorectal cancer prevention and surveillance Manufacturing and Service Operations Management. 16: 381-400. DOI: 10.1287/Msom.2014.0484  0.354
2013 Alagoz O, Chhatwal J, Burnside ES. Optimal Policies for Reducing Unnecessary Follow-up Mammography Exams in Breast Cancer Diagnosis. Decision Analysis : a Journal of the Institute For Operations Research and the Management Sciences. 10: 200-224. PMID 24501588 DOI: 10.1287/Deca.2013.0272  0.684
2013 Wu Y, Alagoz O, Ayvaci MU, Munoz Del Rio A, Vanness DJ, Woods R, Burnside ES. A comprehensive methodology for determining the most informative mammographic features. Journal of Digital Imaging. 26: 941-7. PMID 23503987 DOI: 10.1007/S10278-013-9588-5  0.769
2013 Batina NG, Trentham-Dietz A, Gangnon RE, Sprague BL, Rosenberg MA, Stout NK, Fryback DG, Alagoz O. Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Research and Treatment. 138: 519-28. PMID 23417335 DOI: 10.1007/S10549-013-2435-Z  0.493
2013 Ayvaci MU, Shi J, Alagoz O, Lubner SJ. Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 33: 521-32. PMID 23313932 DOI: 10.1177/0272989X12470755  0.723
2012 Ayvaci MU, Alagoz O, Burnside ES. The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Manufacturing & Service Operations Management : M & Som. 14: 600-617. PMID 24027436 DOI: 10.1287/Msom.1110.0371  0.75
2012 Burnside ES, Chhatwal J, Alagoz O. What is the optimal threshold at which to recommend breast biopsy? Plos One. 7: e48820. PMID 23144986 DOI: 10.1371/Journal.Pone.0048820  0.658
2012 van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Annals of Internal Medicine. 156: 609-17. PMID 22547470 DOI: 10.1097/01.Ogx.0000418532.21029.Ea  0.461
2012 Akan M, Alagoz O, Ata B, Erenay FS, Said A. A broader view of designing the liver allocation system Operations Research. 60: 757-770. DOI: 10.1287/Opre.1120.1064  0.303
2012 Ayer T, Alagoz O, Stout NK. OR forum-A POMDP approach to personalize mammography screening decisions Operations Research. 60: 1019-1034. DOI: 10.1287/Opre.1110.1019  0.377
2012 Van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DSM, Huang H, Heijnsdijk EAM, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: A comparative modeling study of risk: Editorial Comment Obstetrical and Gynecological Survey. 67: 481-482. DOI: 10.1097/01.Ogx.0000418532.21029.Ea  0.322
2011 Erenay FS, Alagoz O, Banerjee R, Cima RR. Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 31: 611-24. PMID 21212440 DOI: 10.1177/0272989X10391809  0.321
2011 Trentham-Dietz A, Sprague B, Alagoz O, Reaidi P, Rosenberg M, Gangnon R, Stout N. The Impact of Detection and Treatment of Carcinoma In Situ on Breast Cancer Mortality Cancer Epidemiology Biomarkers & Prevention. 20: 720-720. DOI: 10.1158/1055-9965.Epi-11-0096  0.517
2010 Chhatwal J, Alagoz O, Burnside ES. Optimal Breast Biopsy Decision-Making Based on Mammographic Features and Demographic Factors. Operations Research. 58: 1577-1591. PMID 21415931 DOI: 10.1287/Opre.1100.0877  0.648
2010 Ayer T, Ayvaci MU, Liu ZX, Alagoz O, Burnside ES. Computer-aided diagnostic models in breast cancer screening. Imaging in Medicine. 2: 313-323. PMID 20835372 DOI: 10.2217/Iim.10.24  0.774
2010 Ayer T, Alagoz O, Chhatwal J, Shavlik JW, Kahn CE, Burnside ES. Breast cancer risk estimation with artificial neural networks revisited: discrimination and calibration. Cancer. 116: 3310-21. PMID 20564067 DOI: 10.1002/Cncr.25081  0.623
2010 Alagoz O, Hsu H, Schaefer AJ, Roberts MS. Markov decision processes: a tool for sequential decision making under uncertainty. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 30: 474-83. PMID 20044582 DOI: 10.1177/0272989X09353194  0.632
2010 Ayer T, Chhatwal J, Alagoz O, Kahn CE, Woods RW, Burnside ES. Informatics in radiology: comparison of logistic regression and artificial neural network models in breast cancer risk estimation. Radiographics : a Review Publication of the Radiological Society of North America, Inc. 30: 13-22. PMID 19901087 DOI: 10.1148/Rg.301095057  0.642
2010 Shechter SM, Alagoz O, Roberts MS. Irreversible treatment decisions under consideration of the research and development pipeline for new therapies Iie Transactions (Institute of Industrial Engineers). 42: 632-642. DOI: 10.1080/07408170903468589  0.331
2009 Burnside ES, Davis J, Chhatwal J, Alagoz O, Lindstrom MJ, Geller BM, Littenberg B, Shaffer KA, Kahn CE, Page CD. Probabilistic computer model developed from clinical data in national mammography database format to classify mammographic findings. Radiology. 251: 663-72. PMID 19366902 DOI: 10.1148/Radiol.2513081346  0.562
2009 Chhatwal J, Alagoz O, Lindstrom MJ, Kahn CE, Shaffer KA, Burnside ES. A logistic regression model based on the national mammography database format to aid breast cancer diagnosis. Ajr. American Journal of Roentgenology. 192: 1117-27. PMID 19304723 DOI: 10.2214/Ajr.07.3345  0.693
2008 Sandikçi B, Maillart LM, Schaefer AJ, Alagoz O, Roberts MS. Estimating the patient's price of privacy in liver transplantation Operations Research. 56: 1393-1410. DOI: 10.1287/Opre.1080.0648  0.342
2005 Alagoz O, Bryce CL, Shechter S, Schaefer A, Chang CC, Angus DC, Roberts MS. Incorporating biological natural history in simulation models: empirical estimates of the progression of end-stage liver disease. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 25: 620-32. PMID 16282213 DOI: 10.1177/0272989X05282719  0.638
2005 Shechter SM, Bryce CL, Alagoz O, Kreke JE, Stahl JE, Schaefer AJ, Angus DC, Roberts MS. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process. Medical Decision Making : An International Journal of the Society For Medical Decision Making. 25: 199-209. PMID 15800304 DOI: 10.1177/0272989X04268956  0.6
Show low-probability matches.